Skip to main content

Table 2 Baseline and demographic data for non-PG-l vs. PG-l patients

From: Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a “real world” STEMI population: results from the Italian “CARDIO-STEMI SANREMO” registry

  Non-PG-l patients
(n = 335)
PG-l patients
(n = 751)
P value
Median (IQR) age, years 54 (49–59) 71 (63–79)  < 0.001
Age ≥ 65 years 44 (13.1) 557 (74.2)  < 0.001
Age ≥ 75 years 26 (7.8) 309 (41.1)  < 0.001
Sex (male) 227 (82.7) 521 (69.4)  < 0.001
Median (IQR) BMI, kg/m2 27 (24–29) 26 (24–29) 0.008
Diabetes mellitus 21 (6.3) 168 (22.4)  < 0.001
GFR < 60 mL/min/1.73m2 22 (6.6) 279 (38.2)  < 0.001
Multivessel CAD 47 (14.0) 393 (52.3)  < 0.001
Previous bleeding 54 (16.2) 0  < 0.001
Previous AMI 16 (4.8) 90 (12.0)  < 0.001
Previous neoplasia 29 (8.7) 117 (15.6) 0.002
TIA 6 (1.8) 21 (2.8) 0.326
Hypertension 140 (41.8) 465 (61.9)  < 0.001
Dyslipidemia 109 (32.5) 270 (36.0) 0.276
Smokers 202 (60.3) 234 (31.2)  < 0.001
Ex-smokers 42 (12.5) 192 (25.6)  < 0.001
Family history of CAD 112 (33.4) 125 (16.6)  < 0.001
  1. Data are expressed as n (%) unless otherwise stated
  2. AMI acute myocardial infarction, BMI body mass index, CAD coronary artery disease, GFR glomerular filtration rate, IQR interquartile range, PG-l PEGASUS-TIMI 54-like patients, TIA transient ischemic attack